ReNeuron shares clinical data on stem cell vision loss therapy

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 14, 2019 at 10:32 AM.

  1. #1 cafead, Oct 14, 2019 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via ReNeuron has presented detailed data from a phase 1/2a clinical trial of its stem cell treatment for retinitis pigmentosa. Shares in ReNeuron fell more than one-third after the release of top-line data at the start of the month, but the biotech argued the detailed results are positive for its prospects.

    article source
     
    Quote

Reply to Thread